Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Major Manufacturers Covered in This Report 1.3 Market Segment by Type 1.3.1 Global Daptomycin Market Size Growth Rate by Type (2019-2025) 1.3.2 350 mg lyophilized powder 1.3.3 500 mg lyophilized powder 1.4 Market Segment by Application 1.4.1 Global Daptomycin Market Share by Application (2019-2025) 1.4.2 Adult 1.4.3 Pediatric patients (1 to 17 years of age) 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Daptomycin Market Size 2.1.1 Global Daptomycin Revenue 2014-2025 2.1.2 Global Daptomycin Sales 2014-2025 2.2 Daptomycin Growth Rate by Regions 2.2.1 Global Daptomycin Sales by Regions 2014-2019 2.2.2 Global Daptomycin Revenue by Regions 2014-2019 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 3 Market Share by Manufacturers 3.1 Daptomycin Sales by Manufacturers 3.1.1 Daptomycin Sales by Manufacturers 2014-2019 3.1.2 Daptomycin Sales Market Share by Manufacturers 2014-2019 3.2 Revenue by Manufacturers 3.2.1 Daptomycin Revenue by Manufacturers (2014-2019) 3.2.2 Daptomycin Revenue Share by Manufacturers (2014-2019) 3.2.3 Global Daptomycin Market Concentration Ratio (CR5 and HHI) 3.3 Daptomycin Price by Manufacturers 3.4 Key Manufacturers Daptomycin Plants/Factories Distribution and Area Served 3.5 Date of Key Manufacturers Enter into Daptomycin Market 3.6 Key Manufacturers Daptomycin Product Offered 3.7 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Sales and Revenue for Each Type 4.1.1 350 mg lyophilized powder Sales and Revenue (2014-2019) 4.1.2 500 mg lyophilized powder Sales and Revenue (2014-2019) 4.2 Global Daptomycin Sales Market Share by Type 4.3 Global Daptomycin Revenue Market Share by Type 4.4 Daptomycin Price by Type 5 Market Size by Application 5.1 Overview 5.2 Global Daptomycin Sales by Application 6 United States 6.1 United States Daptomycin Breakdown Data by Company 6.2 United States Daptomycin Breakdown Data by Type 6.3 United States Daptomycin Breakdown Data by Application 7 European Union 7.1 European Union Daptomycin Breakdown Data by Company 7.2 European Union Daptomycin Breakdown Data by Type 7.3 European Union Daptomycin Breakdown Data by Application 8 China 8.1 China Daptomycin Breakdown Data by Company 8.2 China Daptomycin Breakdown Data by Type 8.3 China Daptomycin Breakdown Data by Application 9 Rest of World 9.1 Rest of World Daptomycin Breakdown Data by Company 9.2 Rest of World Daptomycin Breakdown Data by Type 9.3 Rest of World Daptomycin Breakdown Data by Application 9.4 Rest of World Daptomycin Breakdown Data by Countries 9.4.1 Rest of World Daptomycin Sales by Countries 9.4.2 Rest of World Daptomycin Revenue by Countries 9.4.3 Japan 9.4.4 Korea 9.4.5 India 9.4.6 Southeast Asia 10 Company Profiles 10.1 Merck & Co. 10.1.1 Merck & Co. Company Details 10.1.2 Company Description and Business Overview 10.1.3 Sales, Revenue and Market Share of Daptomycin 10.1.4 Daptomycin Product Introduction 10.1.5 Merck & Co. Recent Development 10.2 Pfizer 10.2.1 Pfizer Company Details 10.2.2 Company Description and Business Overview 10.2.3 Sales, Revenue and Market Share of Daptomycin 10.2.4 Daptomycin Product Introduction 10.2.5 Pfizer Recent Development 10.3 Teva 10.3.1 Teva Company Details 10.3.2 Company Description and Business Overview 10.3.3 Sales, Revenue and Market Share of Daptomycin 10.3.4 Daptomycin Product Introduction 10.3.5 Teva Recent Development 10.4 Mylan 10.4.1 Mylan Company Details 10.4.2 Company Description and Business Overview 10.4.3 Sales, Revenue and Market Share of Daptomycin 10.4.4 Daptomycin Product Introduction 10.4.5 Mylan Recent Development 10.5 Fresenius Kabi 10.5.1 Fresenius Kabi Company Details 10.5.2 Company Description and Business Overview 10.5.3 Sales, Revenue and Market Share of Daptomycin 10.5.4 Daptomycin Product Introduction 10.5.5 Fresenius Kabi Recent Development 10.6 Sagent Pharmaceuticals 10.6.1 Sagent Pharmaceuticals Company Details 10.6.2 Company Description and Business Overview 10.6.3 Sales, Revenue and Market Share of Daptomycin 10.6.4 Daptomycin Product Introduction 10.6.5 Sagent Pharmaceuticals Recent Development 10.7 Xellia 10.7.1 Xellia Company Details 10.7.2 Company Description and Business Overview 10.7.3 Sales, Revenue and Market Share of Daptomycin 10.7.4 Daptomycin Product Introduction 10.7.5 Xellia Recent Development 10.8 Hisun 10.8.1 Hisun Company Details 10.8.2 Company Description and Business Overview 10.8.3 Sales, Revenue and Market Share of Daptomycin 10.8.4 Daptomycin Product Introduction 10.8.5 Hisun Recent Development 10.9 HENGRUI PHARMA 10.9.1 HENGRUI PHARMA Company Details 10.9.2 Company Description and Business Overview 10.9.3 Sales, Revenue and Market Share of Daptomycin 10.9.4 Daptomycin Product Introduction 10.9.5 HENGRUI PHARMA Recent Development 10.10 Huadong Medicine 10.10.1 Huadong Medicine Company Details 10.10.2 Company Description and Business Overview 10.10.3 Sales, Revenue and Market Share of Daptomycin 10.10.4 Daptomycin Product Introduction 10.10.5 Huadong Medicine Recent Development 11 Value Chain and Sales Channels Analysis 11.1 Value Chain Analysis 11.2 Sales Channels Analysis 11.2.1 Daptomycin Sales Channels 11.2.2 Daptomycin Distributors 11.3 Daptomycin Customers 12 Market Forecast 12.1 Global Daptomycin Sales and Revenue Forecast 2019-2025 12.2 Global Daptomycin Sales Forecast by Type 12.3 Global Daptomycin Sales Forecast by Application 12.4 Daptomycin Forecast by Regions 12.4.1 Global Daptomycin Sales Forecast by Regions 2019-2025 12.4.2 Global Daptomycin Revenue Forecast by Regions 2019-2025 12.5 United States Market Forecast 12.6 European Union Market Forecast 12.7 China Market Forecast 12.8 Rest of World 12.8.1 Japan 12.8.2 Korea 12.8.3 India 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables and Figures Figure Daptomycin Product Picture Table Daptomycin Key Market Segments Table Major Manufacturers Daptomycin Covered in This Report Table Global Daptomycin Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$) Figure Global Daptomycin Sales Market Shar by Type 2014-2025 Figure 350 mg lyophilized powder Figures Table Major Manufacturers of 350 mg lyophilized powder Figure 500 mg lyophilized powder Figures Table Major Manufacturers of 500 mg lyophilized powder Table Global Daptomycin Market Share by Application 2019-2025 (K Units) Figure Adult Use Case Figure Pediatric patients (1 to 17 years of age) Use Case Figure Daptomycin Report Years Considered Figure Global Daptomycin Market Size 2014-2025 (Million US$) Figure Global Daptomycin Sales 2014-2019 (K Units) Table Global Daptomycin Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Daptomycin Sales by Regions 2014-2019 (K Units) Table Global Daptomycin Sales Market Share by Regions 2014-2019 Figure Global Daptomycin Sales Market Share by Regions 2014-2019 Figure Global Daptomycin Sales Market Share by Regions in 2019 Table Global Daptomycin Revenue by Regions 2014-2019 (Million US$) Table Global Daptomycin Revenue Market Share by Regions 2014-2019 Figure Global Daptomycin Revenue Market Share by Regions 2014-2019 Figure Global Daptomycin Revenue Market Share by Regions in 2019 Table Market Top Trends Table Global Daptomycin Sales by Manufacturers (2014-2019) (K Units) Table Global Daptomycin Sales Share by Manufacturers (2014-2019) Figure Global Daptomycin Sales Share by Manufacturers in 2019 Table Daptomycin Revenue by Manufacturers (2014-2019) (Million USD) Table Daptomycin Revenue Share by Manufacturers (2014-2019) Figure Daptomycin Value Share by Manufacturers in 2019 Table Global Daptomycin Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Daptomycin Price (2014-2019) (USD/Unit) Table Key Manufacturers Daptomycin Plants/Factories Distribution Table Key Manufacturers Daptomycin Area Served Table Date of Key Manufacturers Enter into Daptomycin Market Table Key Manufacturers Daptomycin Product Type Table Mergers & Acquisitions, Expansion Plans Table Global 350 mg lyophilized powder Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global 500 mg lyophilized powder Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Daptomycin Sales by Type (2014-2019) (K Units) Table Global Daptomycin Sales Share by Type (2014-2019) Figure Global Daptomycin Sales Market Share by Type (2014-2019) Figure Global Daptomycin Sales Market Share by Type in 2018 Table Global Daptomycin Revenue by Type (2014-2019) (Million US$) Table Global Daptomycin Revenue Share by Type (2014-2019) Figure Global Daptomycin Revenue Market Share by Type (2014-2019) Figure Global Daptomycin Revenue Market Share by Type in 2018 Table Daptomycin Price by Type 2014-2019 (USD/Unit) Table Global Daptomycin Sales by Application (2014-2019) (K Units) Table Global Daptomycin Sales Share by Application (2014-2019) Figure Global Sales Daptomycin Market Share by Application (2014-2019) Figure Global Sales Daptomycin Market Share by Application (2014-2019) Figure United States Daptomycin Sales Growth Rate 2014-2019 (K Units) Figure United States Daptomycin Revenue Growth Rate 2014-2019 (Million US$) Table United States Daptomycin Sales by Company (2014-2019) (K Units) Table United States Daptomycin Sales Market Share by Company (2014-2019) Figure United States Daptomycin Sales Market Share by Company in 2019 Table United States Daptomycin Sales by Type (2014-2019) (K Units) Table United States Daptomycin Sales Market Share by Type (2014-2019) Figure United States Daptomycin Market Share by Type in 2019 Table United States Daptomycin Sales by Application (2014-2019) (K Units) Table United States Daptomycin Sales Market Share by Application (2014-2019) Figure United States Daptomycin Market Share by Application in 2019 Figure European Union Daptomycin Sales Growth Rate 2014-2019 (K Units) Figure European Union Daptomycin Revenue Growth Rate 2014-2019 (Million US$) Table European Union Daptomycin Sales by Company (2014-2019) (K Units) Table European Union Daptomycin Sales Market Share by Company (2014-2019) Figure European Union Daptomycin Sales Market Share by Company in 2019 Table European Union Daptomycin Sales by Type (2014-2019) (K Units) Table European Union Daptomycin Sales Market Share by Type (2014-2019) Figure 2018 European Union Daptomycin Market Share by Type Table European Union Daptomycin Sales by Application (2014-2019) (K Units) Table European Union Daptomycin Sales Market Share by Application (2014-2019) Figure 2018 European Union Daptomycin Market Share by Application Figure China Daptomycin Sales Growth Rate 2014-2019 (K Units) Figure China Daptomycin Revenue Growth Rate 2014-2019 (Million US$) Table China Daptomycin Sales by Company (2014-2019) (K Units) Table China Daptomycin Sales Market Share by Company (2014-2019) Figure China Daptomycin Sales Market Share by Company in 2019 Table China Daptomycin Sales by Type (2014-2019) (K Units) Table China Daptomycin Sales Market Share by Type (2014-2019) Figure China Daptomycin Market Share by Type in 2019 Table China Daptomycin Sales by Application (2014-2019) (K Units) Table China Daptomycin Sales Market Share by Application (2014-2019) Figure China Daptomycin Market Share by Application in 2019 Figure Rest of World Daptomycin Sales Growth Rate 2014-2019 (K Units) Figure Rest of World Daptomycin Revenue Growth Rate 2014-2019 (Million US$) Table Rest of World Daptomycin Sales by Company (2014-2019) (K Units) Table Rest of World Daptomycin Sales Market Share by Company (2014-2019) Figure Rest of World Daptomycin Sales Market Share by Company in 2019 Table Rest of World Daptomycin Sales by Type (2014-2019) (K Units) Table Rest of World Daptomycin Sales Market Share by Type (2014-2019) Figure Rest of World Daptomycin Market Share by Type in 2019 Table Rest of World Daptomycin Sales by Application (2014-2019) (K Units) Table Rest of World Daptomycin Sales Market Share by Application (2014-2019) Figure Rest of World Daptomycin Market Share by Application in 2019 Table Rest of World Daptomycin Sales by Countries (2014-2019) (K Units) Table Rest of World Daptomycin Sales Market Share by Countries (2014-2019) Figure Rest of World Daptomycin Sales Market Share by Countries in 2019 Table Rest of World Daptomycin Revenue by Countries (2014-2019) (Million US$) Table Rest of World Daptomycin Revenue Market Share by Countries (2014-2019) Figure Rest of World Daptomycin Revenue Market Share by Countries in 2019 Figure Japan Daptomycin Sales Growth Rate (2014-2019) (K Units) Figure Japan Daptomycin Revenue Growth Rate (2014-2019) (K Units) Figure Korea Daptomycin Sales Growth Rate (2014-2019) (K Units) Figure Korea Daptomycin Revenue Growth Rate (2014-2019) (K Units) Figure India Daptomycin Sales Growth Rate (2014-2019) (K Units) Figure India Daptomycin Revenue Growth Rate (2014-2019) (K Units) Figure Southeast Asia Daptomycin Sales Growth Rate (2014-2019) (K Units) Figure Southeast Asia Daptomycin Revenue Growth Rate (2014-2019) (K Units) Table Merck & Co. Company Details Table Merck & Co. Description and Business Overview Table Merck & Co. Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Merck & Co. Daptomycin Sales Growth Rate (2014-2019) Table Merck & Co. Daptomycin Sales Market Share in Global Market Table Merck & Co. Recent Development Table Pfizer Company Details Table Pfizer Description and Business Overview Table Pfizer Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Daptomycin Sales Growth Rate (2014-2019) Table Pfizer Daptomycin Sales Market Share in Global Market Table Pfizer Recent Development Table Teva Company Details Table Teva Description and Business Overview Table Teva Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Teva Daptomycin Sales Growth Rate (2014-2019) Table Teva Daptomycin Sales Market Share in Global Market Table Teva Recent Development Table Mylan Company Details Table Mylan Description and Business Overview Table Mylan Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Mylan Daptomycin Sales Growth Rate (2014-2019) Table Mylan Daptomycin Sales Market Share in Global Market Table Mylan Recent Development Table Fresenius Kabi Company Details Table Fresenius Kabi Description and Business Overview Table Fresenius Kabi Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Fresenius Kabi Daptomycin Sales Growth Rate (2014-2019) Table Fresenius Kabi Daptomycin Sales Market Share in Global Market Table Fresenius Kabi Recent Development Table Sagent Pharmaceuticals Company Details Table Sagent Pharmaceuticals Description and Business Overview Table Sagent Pharmaceuticals Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Sagent Pharmaceuticals Daptomycin Sales Growth Rate (2014-2019) Table Sagent Pharmaceuticals Daptomycin Sales Market Share in Global Market Table Sagent Pharmaceuticals Recent Development Table Xellia Company Details Table Xellia Description and Business Overview Table Xellia Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Xellia Daptomycin Sales Growth Rate (2014-2019) Table Xellia Daptomycin Sales Market Share in Global Market Table Xellia Recent Development Table Hisun Company Details Table Hisun Description and Business Overview Table Hisun Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Hisun Daptomycin Sales Growth Rate (2014-2019) Table Hisun Daptomycin Sales Market Share in Global Market Table Hisun Recent Development Table HENGRUI PHARMA Company Details Table HENGRUI PHARMA Description and Business Overview Table HENGRUI PHARMA Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table HENGRUI PHARMA Daptomycin Sales Growth Rate (2014-2019) Table HENGRUI PHARMA Daptomycin Sales Market Share in Global Market Table HENGRUI PHARMA Recent Development Table Huadong Medicine Company Details Table Huadong Medicine Description and Business Overview Table Huadong Medicine Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Huadong Medicine Daptomycin Sales Growth Rate (2014-2019) Table Huadong Medicine Daptomycin Sales Market Share in Global Market Table Huadong Medicine Recent Development Figure Daptomycin Value Chain Table Daptomycin Distributors List Table Daptomycin Customers List Table Global Daptomycin Sales Forecast 2019-2025 (K Units) & (Million US$) Figure Global Daptomycin Sales Forecast 2019-2025 (K Units) Figure Global Daptomycin Revenue Forecast 2019-2025 (Million US$) Table Global Daptomycin Sales Forecast by Type 2019-2025 (K Units) Figure Global Daptomycin Sales Forecast by Type 2019-2025 (K Units) Figure Global Daptomycin Sales Market Share Forecast by Type 2019-2025 Table Global Daptomycin Sales Forecast by Application 2019-2025 (K Units) Figure Global Daptomycin Sales Forecast by Application 2019-2025 (K Units) Figure Global Daptomycin Sales Market Share Forecast by Application 2019-2025 Table Global Daptomycin Sales Forecast by Regions 2019-2025 (K Units) Figure Global Daptomycin Sales Forecast by Regions 2019-2025 (K Units) Figure Global Daptomycin Sales Market Share Forecast by Regions 2019-2025 Table Global Daptomycin Revenue Forecast by Regions 2019-2025 (K Units) Figure Global Daptomycin Revenue Forecast by Regions 2019-2025 (K Units) Figure Global Daptomycin Revenue Market Share Forecast by Regions 2019-2025 Figure United States Daptomycin Sales Forecast 2019-2025 (K Units) Figure United States Daptomycin Revenue Forecast 2019-2025 (Million US$) Figure European Union Daptomycin Sales Forecast 2019-2025 (K Units) Figure European Union Daptomycin Revenue Forecast 2019-2025 (Million US$) Figure China Daptomycin Sales Forecast 2019-2025 (K Units) Figure China Daptomycin Revenue Forecast 2019-2025 (Million US$) Figure Japan Daptomycin Sales Forecast 2019-2025 (K Units) Figure Japan Daptomycin Revenue Forecast 2019-2025 (Million US$) Figure Korea Daptomycin Sales Forecast 2019-2025 (K Units) Figure Korea Daptomycin Revenue Forecast 2019-2025 (Million US$) Figure India Daptomycin Sales Forecast 2019-2025 (K Units) Figure India Daptomycin Revenue Forecast 2019-2025 (Million US$) Figure Southeast Asia Daptomycin Sales Forecast 2019-2025 (K Units) Figure Southeast Asia Daptomycin Revenue Forecast 2019-2025 (Million US$) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Merck & Co. Pfizer Teva Mylan Fresenius Kabi Sagent Pharmaceuticals Xellia Hisun HENGRUI PHARMA Huadong Medicine